136 related articles for article (PubMed ID: 9044031)
21. Bactericidal effect of combinations of cephalosporins with tobramycin on clinical isolates of Escherichia coli, Klebsiella and Staphylococcus aureus.
Wagenvoort JH; Brus-Weijer L; Michel MF
Arzneimittelforschung; 1986 Sep; 36(9):1301-2. PubMed ID: 3539124
[TBL] [Abstract][Full Text] [Related]
22. Interference by subinhibitory concentrations of azithromycin with the mechanism of bacterial adhesion to human epithelial cells.
Braga PC; Piatti G
Chemotherapy; 1993; 39(6):432-7. PubMed ID: 8222872
[TBL] [Abstract][Full Text] [Related]
23. An evaluation of the bacteriolytic and biochemical properties of ceftiolene (42980RP).
Williamson R; Gutmann L; Kitzis MD; Acar JF
J Antimicrob Chemother; 1984 Dec; 14(6):581-93. PubMed ID: 6394571
[TBL] [Abstract][Full Text] [Related]
24. Effect of ceftriaxone on Pseudomonas aeruginosa and Staphylococcus aureus in broth, serum, and in combination with human polymorphonuclear leukocytes.
Bassler M; Blaschke H; Just M; Daschner FD
Chemotherapy; 1982; 28(5):390-6. PubMed ID: 6291868
[TBL] [Abstract][Full Text] [Related]
25. Antibacterial activity and penicillin-binding protein affinity of new cephalosporin derivatives in Staphylococcus aureus and Escherichia coli.
Singh MP; Lee YI; Singh R; Micetich RG; Wilkinson BJ
J Antimicrob Chemother; 1991 Apr; 27(4):459-68. PubMed ID: 1856125
[TBL] [Abstract][Full Text] [Related]
26. Antagonistic effect of chloramphenicol in combination with cefotaxime or ceftriaxone.
Asmar BI; Prainito M; Dajani AS
Antimicrob Agents Chemother; 1988 Sep; 32(9):1375-8. PubMed ID: 3195999
[TBL] [Abstract][Full Text] [Related]
27. Decrease in surface charge density of Klebsiella pneumoniae treated with cefodizime and enhancement of the phagocytic function of human polymorphonuclear leucocytes stimulated by the drug-treated bacteria.
Muratsugu M; Miyake Y; Ishida N; Hyodo A; Terayama K
Biol Pharm Bull; 1995 Sep; 18(9):1259-63. PubMed ID: 8845818
[TBL] [Abstract][Full Text] [Related]
28. Influence of sub-minimum inhibitory concentrations of cefodizime on the phagocytosis, intracellular killing and oxidative bursts of human polymorphonuclear leukocytes.
Braga PC; Dal Sasso M; Mancini L; Sala MT
Chemotherapy; 1999; 45(3):166-74. PubMed ID: 10224338
[TBL] [Abstract][Full Text] [Related]
29. In vitro antibacterial activity of cefotaxime and desacetylcefotaxime, alone or in combination, against gram-positive cocci.
Cruciani M; Navarra A; Di Perri G; Danzi MC; Concia E; Bassetti D
Drugs Exp Clin Res; 1990; 16(11):565-8. PubMed ID: 2101779
[TBL] [Abstract][Full Text] [Related]
30. [In vitro antibacterial activity of cefodizime (HR 221) on 323 hospital strains of Gram negative bacilli. Comparison with cefotiam, cefoperazone, cefotetan and cefotaxime].
Le Noc P; Bryskier A; Le Noc D
Pathol Biol (Paris); 1985 May; 33(5):399-403. PubMed ID: 3897972
[TBL] [Abstract][Full Text] [Related]
31. In vitro activity of ceftazidime and ceftriaxone.
Keenholtz SL; Jacobus NV; Tally FP; Gorbach SL
Clin Ther; 1983; 5(6):603-16. PubMed ID: 6313195
[TBL] [Abstract][Full Text] [Related]
32. Bactericidal activity of cefodizime on Enterobacteriaceae in an in-vitro model simulating plasma pharmacokinetics in humans.
Péchinot A; Neuwirth C; Bryskier A; Duez JM; Kazmierczak A
J Antimicrob Chemother; 1997 Feb; 39(2):157-62. PubMed ID: 9069535
[TBL] [Abstract][Full Text] [Related]
33. Mechanism of enhancement of bactericidal activity of phagocytes against Klebsiella pneumoniae treated with subminimal inhibitory concentrations of cefodizime.
Nomura S; Nagayama A
Chemotherapy; 1995; 41(4):267-75. PubMed ID: 7555207
[TBL] [Abstract][Full Text] [Related]
34. Influence of subinhibitory concentrations of cefotaxime, imipenem and ciprofloxacin on adhesion of Escherichia coli strains to polystyrene.
Zalas-Wiecek P; Gospodarek E; Piecyk K
Pol J Microbiol; 2011; 60(4):345-9. PubMed ID: 22390071
[TBL] [Abstract][Full Text] [Related]
35. [Microbiological evaluation of the antibacterial activity of cefotaxime in comparison with other cephalosporins].
Concia E; Marone P; Verani D; Marino P
Boll Ist Sieroter Milan; 1982; 61(4):300-8. PubMed ID: 6100233
[TBL] [Abstract][Full Text] [Related]
36. Morphostructural damage and the inhibition of bacterial adhesiveness of Staphylococcus aureus and Moraxella catarrhalis induced by moxifloxacin.
Braga PC; Culici M; Ricci D; Dal Sasso M
J Chemother; 2003 Dec; 15(6):543-50. PubMed ID: 14998077
[TBL] [Abstract][Full Text] [Related]
37. [In vitro antibacterial activity of a new cephalosporin: cefpirome (HR 810). Comparison with ceftriaxone, cefotaxime, latamoxef and ceftazidime].
Le Noc P; Bryskier A; Le Noc D
Pathol Biol (Paris); 1986 Jun; 34(5 Pt 2):567-71. PubMed ID: 3534744
[TBL] [Abstract][Full Text] [Related]
38. [Activity of fourth generation cephalosporins against clinical isolates of Enterobacteriaceae].
Tuchiluş C; Poiată A; Bădicuţ I; Teodor A; Luca V; Grigore L; Buiuc D
Rev Med Chir Soc Med Nat Iasi; 2003; 107(3):595-8. PubMed ID: 14756068
[TBL] [Abstract][Full Text] [Related]
39. Comparison of cefodizime with various cephalosporins for their indirect effect on the human neutrophil oxidative burst in vitro.
Labro MT; el Benna J
J Antimicrob Chemother; 1990 Nov; 26 Suppl C():49-57. PubMed ID: 2127416
[TBL] [Abstract][Full Text] [Related]
40. Antibiotics and production of granulocyte-macrophage colony-stimulating factor by human bronchial epithelial cells in vitro. A comparison of cefodizime and ceftriaxone.
Pacheco Y; Hosni R; Dagrosa EE; Gormand F; Guibert B; Chabannes B; Lagarde M; Perrin-Fayolle M
Arzneimittelforschung; 1994 Apr; 44(4):559-63. PubMed ID: 8011012
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
